Premium
Hypermetabolism appears to be an adverse prognostic biomarker in amyotrophic lateral sclerosis: a potential for therapeutic intervention?
Author(s) -
Vucic S.
Publication year - 2018
Publication title -
european journal of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.881
H-Index - 124
eISSN - 1468-1331
pISSN - 1351-5101
DOI - 10.1111/ene.13470
Subject(s) - medicine , hypermetabolism , amyotrophic lateral sclerosis , adverse effect , intervention (counseling) , biomarker , oncology , intensive care medicine , physical medicine and rehabilitation , disease , psychiatry , biochemistry , chemistry
Click here to view the accompanying paper in this volume.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom